Market Cap 1.97B
Revenue (ttm) 1.11B
Net Income (ttm) 12.53M
EPS (ttm) N/A
PE Ratio 39.72
Forward PE 46.05
Profit Margin 1.13%
Debt to Equity Ratio 0.00
Volume 551,000
Avg Vol 450,556
Day's Range N/A - N/A
Shares Out 44.88M
Stochastic %K 70%
Beta 0.83
Analysts Sell
Price Target $51.00

Company Profile

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital; and specialized automated dispensing systems for hospitals, health systems, and post-acute care...

Industry: Health Information Services
Sector: Healthcare
Phone: 877 415 9990
Address:
4220 North Freeway, Suite 301, Fort Worth, United States
erevnon
erevnon Dec. 9 at 2:51 PM
Benchmark maintains Omnicell $OMCL at Buy and raises the price target from $45 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
JarvisFlow
JarvisFlow Dec. 9 at 1:12 PM
Benchmark updates rating for Omnicell ( $OMCL ) to Buy, target set at 45 → 50.
0 · Reply
Buymyshares
Buymyshares Dec. 9 at 6:48 AM
$OMCL @SeanDavid Sorry but this is just marketing bullshit. Small software evolution pumped up by the product organisation. The XT is still an old designed machine, manufactured in the Milpitas obsolete and expensive factory.... Omnicell is lacking real innovation and new products vs competition and the long term investors know it - look at the share trends in the last 2 years...
0 · Reply
SeanDavid
SeanDavid Dec. 9 at 12:24 AM
Big news for Omnicell today. Titan XT is live. Because Omnicell runs multiyear product cycles similar to iPhone, this launch matters. The last cycle ended a couple yrs ago. Today marks start of a new upgrade wave, which is important for bookings and backlog. Titan XT is the new automated system, and part of the story is OmniSphere, their cloud platform. It unifies pharmacy / nursing workflows, creates a connected medication network, and brings AI into inventory forecasting and task guidance. So this is big. They sit in a duopoly w Pyxis. However feedback for Pyxis is negative. As hospitals come up for renewal, they have a brand new unified offering against a lack luster competitive product. For $OMCL , looks like early feedback is strong. A system reported 70% time savings on cabinet restocking thanks to OmniSphere’s guided workflows. Investor lens: a new product cycle, shift to cloud intelligence, and platform that can keep compounding. Real step forward. __ $BDX $AAPL
0 · Reply
Estimize
Estimize Dec. 8 at 1:06 PM
Wall St is expecting 0.49 EPS for $OMCL Q4 [Reporting 02/05 BMO] http://www.estimize.com/intro/omcl?chart=historical&metric_name=eps&utm_co
0 · Reply
ZacksResearch
ZacksResearch Dec. 5 at 2:50 PM
$OMCL looks like one of those under-the-radar setups with real legs. An expanding SaaS pipeline, a broader global push, and solid solvency are all pointing to growth potential — even with rising competition in the mix. Dive into the full breakdown here 👉 https://www.zacks.com/stock/news/2800097/reasons-to-add-omnicell-stock-to-your-portfolio-right-now?cid=sm-stocktwits-2-2800097-teaser-23600&ADID=SYND_STOCKTWITS_TWEET_2_2800097_TEASER_23600
0 · Reply
ZacksResearch
ZacksResearch Dec. 5 at 1:51 PM
$OMCL soared 27.8% over the past year — what’s fueling the surge? 🚀 Omnicell's SaaS and Expert Services, global expansion plans, and strong liquidity and capital structure are driving growth 📈. The company boasts a Zacks Rank #2 (Buy) and a 38.7% earnings surprise average over the last four quarters. See what could drive OMCL higher 👉 https://www.zacks.com/stock/news/2800097/reasons-to-add-omnicell-stock-to-your-portfolio-right-now?cid=sm-stocktwits-2-2800097-body-23587&ADID=SYND_STOCKTWITS_TWEET_2_2800097_BODY_23587
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Dec. 2 at 7:58 PM
$OLMA $OM $OMCL $OMER $OMF Undeniable Accuracy Cycle Trading Signal plugged into AI 🔥 lists 🔥 Math don't lie 🔥
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Nov. 23 at 3:41 PM
0 · Reply
DoctorTy
DoctorTy Nov. 20 at 9:25 PM
$HIMS so now they xay $OMCL is better buy from hims. Any opinions
0 · Reply
Latest News on OMCL
Why Omnicell Stock Crushed the Market Today

Oct 30, 2025, 6:45 PM EDT - 6 weeks ago

Why Omnicell Stock Crushed the Market Today


Omnicell, Inc. (OMCL) Q3 2025 Earnings Call Transcript

Oct 30, 2025, 3:36 PM EDT - 6 weeks ago

Omnicell, Inc. (OMCL) Q3 2025 Earnings Call Transcript


Omnicell Announces Third Quarter 2025 Financial Results

Oct 30, 2025, 6:30 AM EDT - 6 weeks ago

Omnicell Announces Third Quarter 2025 Financial Results


Omnicell Q2 Earnings: Market Ignoring The Segments

Jul 31, 2025, 11:45 AM EDT - 4 months ago

Omnicell Q2 Earnings: Market Ignoring The Segments


Omnicell Announces Second Quarter 2025 Results

Jul 31, 2025, 6:30 AM EDT - 4 months ago

Omnicell Announces Second Quarter 2025 Results


Omnicell Opens New Innovation Lab in Austin, Texas

May 14, 2025, 8:30 AM EDT - 7 months ago

Omnicell Opens New Innovation Lab in Austin, Texas


Omnicell: Facing New Headwinds

May 7, 2025, 1:25 PM EDT - 7 months ago

Omnicell: Facing New Headwinds


Omnicell Announces First Quarter 2025 Results

May 6, 2025, 6:30 AM EDT - 7 months ago

Omnicell Announces First Quarter 2025 Results


Omnicell Announces Chief Financial Officer Transition

Mar 12, 2025, 8:30 AM EDT - 9 months ago

Omnicell Announces Chief Financial Officer Transition


Omnicell Q4 Earnings: Ignore The Short-Term Noise

Feb 12, 2025, 7:44 AM EST - 10 months ago

Omnicell Q4 Earnings: Ignore The Short-Term Noise


Omnicell, Inc. (OMCL) Q4 2024 Earnings Call Transcript

Feb 6, 2025, 1:24 PM EST - 11 months ago

Omnicell, Inc. (OMCL) Q4 2024 Earnings Call Transcript


Omnicell Announces Fiscal Year and Fourth Quarter 2024 Results

Feb 6, 2025, 6:30 AM EST - 11 months ago

Omnicell Announces Fiscal Year and Fourth Quarter 2024 Results


Omnicell Announces OmniSphere

Dec 9, 2024, 8:30 AM EST - 1 year ago

Omnicell Announces OmniSphere


Omnicell Q3 Earnings: Look At The Growth Segment

Nov 1, 2024, 11:58 AM EDT - 1 year ago

Omnicell Q3 Earnings: Look At The Growth Segment


Omnicell, Inc. (OMCL) Q3 2024 Earnings Call Transcript

Oct 30, 2024, 2:07 PM EDT - 1 year ago

Omnicell, Inc. (OMCL) Q3 2024 Earnings Call Transcript


Omnicell Announces Third Quarter 2024 Results

Oct 30, 2024, 6:30 AM EDT - 1 year ago

Omnicell Announces Third Quarter 2024 Results


Omnicell Announces Central Med Automation Service

Aug 20, 2024, 4:30 PM EDT - 1 year ago

Omnicell Announces Central Med Automation Service


Omnicell, Inc. (OMCL) Q2 2024 Earnings Call Transcript

Aug 4, 2024, 1:49 AM EDT - 1 year ago

Omnicell, Inc. (OMCL) Q2 2024 Earnings Call Transcript


Omnicell Announces Second Quarter 2024 Results

Aug 1, 2024, 6:30 AM EDT - 1 year ago

Omnicell Announces Second Quarter 2024 Results


Omnicell, Inc. (OMCL) Q1 2024 Earnings Call Transcript

May 2, 2024, 2:22 PM EDT - 1 year ago

Omnicell, Inc. (OMCL) Q1 2024 Earnings Call Transcript


Omnicell Announces First Quarter 2024 Results

May 2, 2024, 7:30 AM EDT - 1 year ago

Omnicell Announces First Quarter 2024 Results


Omnicell Announces XT Amplify

Apr 16, 2024, 4:01 PM EDT - 1 year ago

Omnicell Announces XT Amplify


Omnicell Is Building A Strong Moat

Feb 22, 2024, 6:20 AM EST - 1 year ago

Omnicell Is Building A Strong Moat


Omnicell, Inc. (OMCL) Q4 2023 Earnings Call Transcript

Feb 8, 2024, 6:03 PM EST - 2 years ago

Omnicell, Inc. (OMCL) Q4 2023 Earnings Call Transcript


erevnon
erevnon Dec. 9 at 2:51 PM
Benchmark maintains Omnicell $OMCL at Buy and raises the price target from $45 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
JarvisFlow
JarvisFlow Dec. 9 at 1:12 PM
Benchmark updates rating for Omnicell ( $OMCL ) to Buy, target set at 45 → 50.
0 · Reply
Buymyshares
Buymyshares Dec. 9 at 6:48 AM
$OMCL @SeanDavid Sorry but this is just marketing bullshit. Small software evolution pumped up by the product organisation. The XT is still an old designed machine, manufactured in the Milpitas obsolete and expensive factory.... Omnicell is lacking real innovation and new products vs competition and the long term investors know it - look at the share trends in the last 2 years...
0 · Reply
SeanDavid
SeanDavid Dec. 9 at 12:24 AM
Big news for Omnicell today. Titan XT is live. Because Omnicell runs multiyear product cycles similar to iPhone, this launch matters. The last cycle ended a couple yrs ago. Today marks start of a new upgrade wave, which is important for bookings and backlog. Titan XT is the new automated system, and part of the story is OmniSphere, their cloud platform. It unifies pharmacy / nursing workflows, creates a connected medication network, and brings AI into inventory forecasting and task guidance. So this is big. They sit in a duopoly w Pyxis. However feedback for Pyxis is negative. As hospitals come up for renewal, they have a brand new unified offering against a lack luster competitive product. For $OMCL , looks like early feedback is strong. A system reported 70% time savings on cabinet restocking thanks to OmniSphere’s guided workflows. Investor lens: a new product cycle, shift to cloud intelligence, and platform that can keep compounding. Real step forward. __ $BDX $AAPL
0 · Reply
Estimize
Estimize Dec. 8 at 1:06 PM
Wall St is expecting 0.49 EPS for $OMCL Q4 [Reporting 02/05 BMO] http://www.estimize.com/intro/omcl?chart=historical&metric_name=eps&utm_co
0 · Reply
ZacksResearch
ZacksResearch Dec. 5 at 2:50 PM
$OMCL looks like one of those under-the-radar setups with real legs. An expanding SaaS pipeline, a broader global push, and solid solvency are all pointing to growth potential — even with rising competition in the mix. Dive into the full breakdown here 👉 https://www.zacks.com/stock/news/2800097/reasons-to-add-omnicell-stock-to-your-portfolio-right-now?cid=sm-stocktwits-2-2800097-teaser-23600&ADID=SYND_STOCKTWITS_TWEET_2_2800097_TEASER_23600
0 · Reply
ZacksResearch
ZacksResearch Dec. 5 at 1:51 PM
$OMCL soared 27.8% over the past year — what’s fueling the surge? 🚀 Omnicell's SaaS and Expert Services, global expansion plans, and strong liquidity and capital structure are driving growth 📈. The company boasts a Zacks Rank #2 (Buy) and a 38.7% earnings surprise average over the last four quarters. See what could drive OMCL higher 👉 https://www.zacks.com/stock/news/2800097/reasons-to-add-omnicell-stock-to-your-portfolio-right-now?cid=sm-stocktwits-2-2800097-body-23587&ADID=SYND_STOCKTWITS_TWEET_2_2800097_BODY_23587
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Dec. 2 at 7:58 PM
$OLMA $OM $OMCL $OMER $OMF Undeniable Accuracy Cycle Trading Signal plugged into AI 🔥 lists 🔥 Math don't lie 🔥
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Nov. 23 at 3:41 PM
0 · Reply
DoctorTy
DoctorTy Nov. 20 at 9:25 PM
$HIMS so now they xay $OMCL is better buy from hims. Any opinions
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Nov. 17 at 10:57 AM
0 · Reply
SuperGreenToday
SuperGreenToday Nov. 12 at 6:54 PM
$OMCL Share Price: $36.99 Contract Selected: May 15, 2026 $35 Calls Buy Zone: $3.74 – $4.62 Target Zone: $6.68 – $8.16 Potential Upside: 69% ROI Time to Expiration: 183 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
ZacksResearch
ZacksResearch Nov. 4 at 4:00 PM
Robotics stocks are heating up for 2025 🔥 $PATH, $EMR, $TRMB, $OMCL and $LECO are all leveraging extensive robotics applications — positioning them for solid momentum into year-end. Find out which of these names could lead the next robotics rally 👉 https://www.zacks.com/stock/news/2784478/buy-5-stocks-with-extensive-robotics-application-for-the-rest-of-2025?cid=sm-stocktwits-2-2784478-teaser-19281&ADID=SYND_STOCKTWITS_TWEET_2_2784478_TEASER_19281
0 · Reply
ZacksResearch
ZacksResearch Nov. 4 at 3:00 PM
Why invest in robotics stocks now? 🤖🚀 Major players like $PATH, $EMR, $TRMB, $OMCL, and $LECO are poised for growth with a mix of Zacks Ranks #1 and #2 and impressive earnings outlooks. With advancements in AI and automation, these stocks could see significant returns. Discover the full list of top picks here 👉 https://www.zacks.com/stock/news/2784478/buy-5-stocks-with-extensive-robotics-application-for-the-rest-of-2025?cid=sm-stocktwits-2-2784478-body-19280&ADID=SYND_STOCKTWITS_TWEET_2_2784478_BODY_19280
0 · Reply
SeanDavid
SeanDavid Oct. 31 at 5:37 PM
$AMZN showed retail efficiency, ads strength, and steady AWS growth. +20% looks like for calendar Q4. Bedrock and Q are pulling workloads from testing to production, creating recurring compute demand rather than GPU one-offs. CAPEX $Z Zillow signaled 2026 growth like 2025, in the teens for revenue. Also expects 2% margin expansion which signals 20% or more earnings power. They only assume flat housing activity. Rentals 40% growth and they expect 45% next Q, which means $1B on track. $OMCL Omnicell expanding its recurring base and cloud becoming part of the software story. Big wins in Q and founder Randall seemed very optimistic. $MCW Mister Car Wash sounded very constructive. Ability to build or buy now. Signals unit growth above street’s 30 annually. Acquired 5 in Lubbock. Margins intact and multiples on acquisitions attractive. Growth story intact and cheap.
0 · Reply
MaverikIT
MaverikIT Oct. 30 at 2:55 PM
$OMCL +3.22 nice ER Omnicell Reports Bullish Q3, Stock Soars
0 · Reply
DonCorleone77
DonCorleone77 Oct. 30 at 10:58 AM
$OMCL Omnicell reports Q3 non-GAAP EPS 51c, consensus 36c -- Q3 revenue $311M, consensus $295.59M. -- Sees Q4 non-GAAP EPS 40c-50c, consensus 48c. -- Sees Q4 revenue $306M-$3169M, consensus $295.32M.
0 · Reply
AlexSwiss77
AlexSwiss77 Oct. 30 at 10:44 AM
$OMCL best on Revenue /EPS !!
0 · Reply
ZacksResearch
ZacksResearch Oct. 7 at 12:35 PM
$OMCL — Can SaaS & Expert Services Fuel a Comeback? 🚀 Despite losing 29.1% over the past year, Omnicell's SaaS and Expert Services could help sustain growth with market demand and geographic expansion plans. Plus, a robust solvency position adds stability. Discover more about OMCL’s growth strategy here 👉 https://www.zacks.com/stock/news/2763380/reasons-to-add-omnicell-stock-to-your-portfolio-right-now?cid=sm-stocktwits-2-2763380-body-14846&ADID=SYND_STOCKTWITS_TWEET_2_2763380_BODY_14846
0 · Reply
ZacksResearch
ZacksResearch Oct. 7 at 11:35 AM
$OMCL — Hidden growth story in healthcare tech? 👀 Expanding SaaS offerings, global expansion plans, and a strong balance sheet are fueling real momentum — even with rising competition in the mix. Discover why OMCL could be a smart addition right now 👉 https://www.zacks.com/stock/news/2763380/reasons-to-add-omnicell-stock-to-your-portfolio-right-now?cid=sm-stocktwits-2-2763380-teaser-14845&ADID=SYND_STOCKTWITS_TWEET_2_2763380_TEASER_14845
0 · Reply
OrtexOracle
OrtexOracle Oct. 5 at 3:36 PM
$OMCL Healthcare technology growth. Testing resistance level. Volume expansion needed for continuation. Sector momentum.
0 · Reply
AlexSwiss77
AlexSwiss77 Sep. 24 at 9:28 PM
$OMCL adding in low 30s
0 · Reply